Identification of Rinvoq:
No description |
Search images on Google Product Monograph
Active Ingredients:
- upadacitinib, 30 MG
DIN: 02520893
Dosage Form(s): TABLET (EXTENDED-RELEASE)
Route(s) of Administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AF - (ATC, WHO)
- L04AF03 - UPADACITINIB (WHO)